Home > Boards > US Listed > Biotechs > Sio Gene Therapies Inc (SIOX)

That P&D trade might have been complicated by

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
keekee Member Profile
 
Followed By 108
Posts 4,097
Boards Moderated 0
Alias Born 09/29/11
160x600 placeholder
Sio Gene Therapies Announces Dosing of First GM1 Gangliosidosis Early Infantile (Type I) Patient in Ongoing Phase 1/2 Study of AXO-AAV-GM1 Gene Therapy GlobeNewswire Inc. - 9/9/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/12/2021 7:23:31 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/12/2021 7:22:24 AM
Sio Gene Therapies Announces Corporate Updates and Fiscal First Quarter 2021 Financial Results GlobeNewswire Inc. - 8/12/2021 7:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 8/6/2021 4:17:51 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 8/6/2021 4:15:59 PM
Sio Gene Therapies EPS beats by $0.12 Seeking Alpha - 6/9/2021 7:11:07 AM
Annual Report (10-k) Edgar (US Regulatory) - 6/9/2021 7:02:38 AM
Sio Gene Therapies Announces Fiscal Year 2020 Year-End Financial Results and Expected Fiscal Year 2021 Key Milestones GlobeNewswire Inc. - 6/9/2021 7:00:00 AM
Sio Gene Therapies to Present at the UBS Global Healthcare Virtual Conference GlobeNewswire Inc. - 5/19/2021 8:00:00 AM
Sio Gene Therapies' AAV9 gene therapy shows beneficial effect in GM1 gangliosidosis in children Seeking Alpha - 5/13/2021 7:32:58 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/13/2021 7:02:02 AM
Sio Gene Therapies Announces CSF Reductions in GM1 Ganglioside from Clinical Trial of AXO-AAV-GM1 Gene Therapy GlobeNewswire Inc. - 5/13/2021 7:00:00 AM
Bristol-Myers cut to neutral at Morgan Stanly noting an ‘uninspired’ pipeline, Community Health upgraded after Q1 results... Seeking Alpha - 4/30/2021 9:25:49 AM
Sio Gene Therapies Announces Four Upcoming Oral Presentations at the 24th Annual Meeting of the American Society of Gene and ... GlobeNewswire Inc. - 4/28/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/19/2021 4:59:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/19/2021 4:56:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/19/2021 4:55:13 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/19/2021 4:54:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/19/2021 4:53:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/19/2021 4:52:22 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/5/2021 5:11:25 PM
Sio Gene Therapies to Participate in Upcoming Conferences GlobeNewswire Inc. - 3/29/2021 8:00:00 AM
Sio Gene CEO discloses insider buying Seeking Alpha - 3/25/2021 3:37:02 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/24/2021 7:22:16 PM
keekee   Tuesday, 11/03/20 08:55:05 AM
Re: SurgeGuy2.0 post# 123
Post # of 164 
That P&D trade might have been complicated by my entry into the stock. If you read my other posts, you may understand why the stock is now under $2. Me!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences